Financial News

Financial Reports: Lilly

Novartis Animal Health, Cyramza and Trulicity boost results

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Lilly 3Q Revenues: $5.0 billion (+2%) 3Q Earnings: $799.7 million (+60%) YTD Revenue: $14.6 billion (+1%) YTD Earnings: $1.9 billion (-2%) Comments: Novartis Animal Health and recently launched Cyramza and Trulicity sales, were partially offset by the unfavorable effect of foreign exchange and the residual impact of the Cymbalta patent expiration. Humalog sales were flat at $709 million in the quarter. Cialis sales were also flat at $566.1 million. Alimta sales declined 13% to $62...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters